News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
The company's test uses self-collected saliva samples from potential parents to assess their future child's genetic predisposition to various diseases.
The firm's revenue decrease was largely driven by a decline in testing volumes due to the COVID-19 pandemic, it said.
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.
During a conference call, company executives also discussed results from the SMART NIPT trial and their outlook for Natera's three businesses.
